Beyond expectations: disease duration and psychological burden in psoriatic arthritis
- PMID: 37418001
- DOI: 10.1007/s00296-023-05379-2
Beyond expectations: disease duration and psychological burden in psoriatic arthritis
Abstract
This study aims to investigate the relationship between disease duration and psychological burden in PsA and to identify the risk factors associated with psychological distress. Patients with PsA who met CASPAR classification criteria enrolled by Turkish League Against Rheumatism (TLAR)-Network. Patients were categorized into three groups based on disease duration: early stage (< 5 years), middle stage (≥ 5, < 10 years), and late stage (≥ 10 years). All patients underwent clinical and laboratory assessment using standardized protocol and case report forms. The associations between psychological variables and clinical parameters were assessed by a multivariate analysis. Of the 1113 patients with PsA (63.9% female), 564 (%50.7) had high risk for depression and 263 (%23.6) for anxiety. The risk of psychological burden was similar across all PsA groups, and patients with a higher risk of depression and anxiety also experienced greater disease activity, poorer quality of life, and physical disability. Multivariate logistic regression revealed that female gender (OR = 1.52), PsAQoL (OR = 1.13), HAQ (OR = 1.99), FiRST score (OR = 1.14), unemployment/retired (OR = 1.48) and PASI head score (OR = 1.41) were factors that influenced the risk of depression, whereas the current or past enthesitis (OR = 1.45), PsAQoL (OR = 1.19), and FiRST score (OR = 1.26) were factors that influenced the risk of anxiety. PsA patients can experience a comparable level of psychological burden throughout the course of their disease. Several socio-demographic and disease-related factors may contribute to mental disorders in PsA. In the present era of personalized treatment for PsA, evaluating psychiatric distress can guide tailored interventions that improve overall well-being and reduce disease burden.
Keywords: Anxiety; Arthritis; Depression; Psoriatic; Quality of life; Rheumatic diseases.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. https://doi.org/10.1136/ard.2004.032482 - DOI - PubMed - PMC
-
- Labitigan M, Bahce-Altuntas A, Kremer JM et al (2014) Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res 66(4):600–607. https://doi.org/10.1002/acr.22185 - DOI
-
- Nas K, Karkucak M, Durmus B et al (2015) Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis. Int J Rheum Dis 18(8):873–879. https://doi.org/10.1111/1756-185X.12580 - DOI - PubMed
-
- Duruoz MT, Gezer HH, Nas K et al (2020) The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network. Rheumatol Int 40(11):1803–1815. https://doi.org/10.1007/s00296-020-04628-y - DOI - PubMed
-
- Haugeberg G, Michelsen B, Kavanaugh A (2020) Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: a cross-sectional study of outpatient clinic patients in the biologic treatment era. RMD Open. https://doi.org/10.1136/rmdopen-2020-001223 - DOI - PubMed - PMC
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
